(Q48198959)

9 February 2018

title

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT. (English)

1 reference

9 February 2018

0 references

1 reference

2

Marek KL

1 reference

9 February 2018

author name string

Innis RB

1

1 reference

9 February 2018

Sheff K

3

1 reference

9 February 2018

Zoghbi S

4

1 reference

9 February 2018

Castronuovo J

5

1 reference

9 February 2018

Feigin A

6

1 reference

9 February 2018

Seibyl JP

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

published in

Movement Disorders

1 reference

9 February 2018

volume

14

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

436-442

1 reference

9 February 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Functional imaging in relation to parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C436%3A%3AAID-MDS1008%3E3.0.CO%3B2-J

10.1002/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018